Literature DB >> 12477818

Disulfide-linked integrase oligomers involving C280 residues are formed in vitro and in vivo but are not essential for human immunodeficiency virus replication.

Julien Bischerour1, Hervé Leh, Eric Deprez, Jean-Claude Brochon, Jean-François Mouscadet.   

Abstract

The human immunodeficiency virus type 1 integrase (IN) forms an oligomer that integrates both ends of the viral DNA. The nature of the active oligomer is unclear. Recombinant IN obtained under reducing conditions is always in the form of noncovalent oligomers. However, disulfide-linked oligomers of IN were recently observed within viral particles. We show that IN produced from a baculovirus expression system can form disulfide-linked oligomers. We investigated which residues are responsible for the disulfide bridges and the relationship between the ability to form covalent dimers and IN activity. Only the mutation of residue C280 was sufficient to prevent the formation of intermolecular disulfide bridges in oligomers of recombinant IN. IN activity was studied under and versus nonreducing conditions: the formation of disulfide bridges was not required for the in vitro activities of the enzyme. Moreover, the covalent dimer does not dissociate into individual protomers on disulfide bridge reduction. Instead, IN undergoes a spontaneous multimerization process that yields a homogenous noncovalent tetramer. The C280S mutation also completely abolished the formation of disulfide bonds in the context of the viral particle. Finally, the replication of the mutant virus was investigated in replicating and arrested cells. The infectivity of the virus was not affected by the C280S IN mutation in either dividing or nondividing cells. The disulfide-linked form of the IN oligomers observed in the viral particles is thus not required for viral replication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477818      PMCID: PMC140589          DOI: 10.1128/jvi.77.1.135-141.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.

Authors:  J C Chen; J Krucinski; L J Miercke; J S Finer-Moore; A H Tang; A D Leavitt; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.

Authors:  K Gao; S L Butler; F Bushman
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.

Authors:  J Y Wang; H Ling; W Yang; R Craigie
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

4.  HIV-1 infection requires a functional integrase NLS.

Authors:  M Bouyac-Bertoia; J D Dvorin; R A Fouchier; Y Jenkins; B E Meyer; L I Wu; M Emerman; M H Malim
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

5.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.

Authors:  C J Burke; G Sanyal; M W Bruner; J A Ryan; R L LaFemina; H L Robbins; A S Zeft; C R Middaugh; M G Cordingley
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

7.  DNA binding induces dissociation of the multimeric form of HIV-1 integrase: a time-resolved fluorescence anisotropy study.

Authors:  E Deprez; P Tauc; H Leh; J F Mouscadet; C Auclair; M E Hawkins; J C Brochon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase.

Authors:  H Leh; P Brodin; J Bischerour; E Deprez; P Tauc; J C Brochon; E LeCam; D Coulaud; C Auclair; J F Mouscadet
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

9.  Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy.

Authors:  E Deprez; P Tauc; H Leh; J F Mouscadet; C Auclair; J C Brochon
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

10.  Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex.

Authors:  A Engelman; F D Bushman; R Craigie
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  13 in total

1.  The role of lysine 186 in HIV-1 integrase multimerization.

Authors:  Lionel Berthoux; Sarah Sebastian; Mark A Muesing; Jeremy Luban
Journal:  Virology       Date:  2007-03-29       Impact factor: 3.616

2.  HIV-1 Antisense Protein of Different Clades Induces Autophagy and Associates with the Autophagy Factor p62.

Authors:  Zhenlong Liu; Cynthia Torresilla; Yong Xiao; Phuong Trang Nguyen; Clément Caté; Karina Barbosa; Éric Rassart; Shan Cen; Steve Bourgault; Benoit Barbeau
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

3.  Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains.

Authors:  Kushol Gupta; Troy Brady; Benjamin M Dyer; Nirav Malani; Young Hwang; Frances Male; Robert T Nolte; Liping Wang; Emile Velthuisen; Jerry Jeffrey; Gregory D Van Duyne; Frederic D Bushman
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  A cooperative and specific DNA-binding mode of HIV-1 integrase depends on the nature of the metallic cofactor and involves the zinc-containing N-terminal domain.

Authors:  Kevin Carayon; Hervé Leh; Etienne Henry; Françoise Simon; Jean-François Mouscadet; Eric Deprez
Journal:  Nucleic Acids Res       Date:  2010-02-17       Impact factor: 16.971

5.  Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.

Authors:  Kai Zhu; Charles Dobard; Samson A Chow
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents.

Authors:  Sabine Bonnenfant; Claire Marie Thomas; Claudio Vita; Frédéric Subra; Eric Deprez; Fatima Zouhiri; Didier Desmaële; Jean D'Angelo; Jean François Mouscadet; Hervé Leh
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid.

Authors:  Deborah J Lee; W E Robinson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

9.  HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn(2+) from nucleocapsid protein.

Authors:  David R Morcock; James A Thomas; Raymond C Sowder; Louis E Henderson; Bruce J Crise; Robert J Gorelick
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

10.  Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes.

Authors:  Tamara Bar-Magen; Richard D Sloan; Verena H Faltenbacher; Daniel A Donahue; Björn D Kuhl; Maureen Oliveira; Hongtao Xu; Mark A Wainberg
Journal:  Retrovirology       Date:  2009-11-11       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.